AAPL 207.5 +0.52 (+0.25%)MSFT 125.42 +0.48 (+0.38%)FB 183.67 +0.21 (+0.11%)ZNGA 5.62 +0.1 (+1.81%)NVDA 190.7 -0.66 (-0.34%)WBA 53.19 -0.53 (-0.99%)GOOG 1264.39 -1.93 (-0.15%)PIH 5.25 -0.05 (-0.94%)
AAPL 207.5 +0.52 (+0.25%)MSFT 125.42 +0.48 (+0.38%)FB 183.67 +0.21 (+0.11%)ZNGA 5.62 +0.1 (+1.81%)NVDA 190.7 -0.66 (-0.34%)WBA 53.19 -0.53 (-0.99%)GOOG 1264.39 -1.93 (-0.15%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ABT Quote Abbott Labo

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 18,620 9,407 3,844
ShortTermInvest 155 203 242
Cash 18,775 9,610 4,086
AccountReceivab 3,248 5,249 5,182
Inventories 2,434 3,601 3,796
DeferredIncomeT 2,263 1,944 1,868
OtherCurrentAss 513 20 9
TotalCurrentAss 26,776 20,147 14,632
PPE 12,366 15,265 15,706
AccumulatedDepr -6,661 -7,658 -8,143
NetPPE 5,705 7,607 7,563
EquityAndOtherI 2,947 883 897
Goodwill 7,683 24,020 23,254
IntangibleAsset 4,539 21,473 18,942
OtherLTAssets 2,753 176 17
TotalNonCurrent 25,890 56,103 52,541
TotalAssets 52,666 76,250 67,173
ShortTermDebt 1,325 714 207
AccountsPayable 1,178 2,402 2,975
TaxesPayable 188 309 305
AccruedLiabilit 3,223 4,874 4,796
DeferredRevenue 0 0 0
OtherCurrentLia 746 613 729
TotalCurrentLia 6,660 8,912 9,012
Debt 20,681 27,210 19,359
DeferredTaxesLi 356 2,006 2,056
DeferredRevenue 0 0 0
OtherLTLiabilit 2,098 4,855 3,984
TotalNonCurrent 25,468 36,441 27,637
TotalLiabilitie 32,128 45,353 36,649
CommonStock 0 0 0
AdditionalPaidI 13,027 23,206 23,512
RetainedEarning 25,565 23,978 24,560
AccumulatedOthe -7,263 -6,062 -7,586
TotalStockholde 20,538 30,897 30,524
TotalLiabilitie 52,666 76,250 67,173
Abbott Laboratories income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Abbott Laboratories FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.